title: New option for primary stroke prevention in sickle cell anaemia.
authors.affiliation: Department of Pediatrics and Medicine, Division of Hematology/Oncology, and Vanderbilt-Meharry Sickle Cell Center for Excellence, Vanderbilt University School of Medicine, Nashville, TN 37232-9000, USA. Electronic address: M.DeBaun@vanderbilt.edu.
authors.forename: Michael R
authors.initials: MR
authors.lastname: DeBaun
authors.affiliation: Developmental Neurosciences, UCL Institute of Child Health, London, UK.
authors.forename: Fenella J
authors.initials: FJ
authors.lastname: Kirkham
mesh_terms: D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000627:therapeutic use*; D001803:Blood Transfusion / Q000379:methods*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea